Yoshikuni Mizuno

37.5k total citations · 6 hit papers
403 papers, 26.7k citations indexed

About

Yoshikuni Mizuno is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Yoshikuni Mizuno has authored 403 papers receiving a total of 26.7k indexed citations (citations by other indexed papers that have themselves been cited), including 255 papers in Neurology, 146 papers in Cellular and Molecular Neuroscience and 116 papers in Molecular Biology. Recurrent topics in Yoshikuni Mizuno's work include Parkinson's Disease Mechanisms and Treatments (210 papers), Neurological disorders and treatments (82 papers) and Nuclear Receptors and Signaling (58 papers). Yoshikuni Mizuno is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (210 papers), Neurological disorders and treatments (82 papers) and Nuclear Receptors and Signaling (58 papers). Yoshikuni Mizuno collaborates with scholars based in Japan, United States and United Kingdom. Yoshikuni Mizuno's co-authors include Nobutaka Hattori, Shuichi Asakawa, Satoshi Minoshima, Nobuyoshi Shimizu, Hiroto Matsumine, Tohru Kitada, Yasuhiro Yamamura, Hideki Mochizuki, Masayuki Yokochi and Tomoyoshi Kondo and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Yoshikuni Mizuno

396 papers receiving 26.2k citations

Hit Papers

Mutations in the parkin gene cause autosomal recessive ju... 1989 2026 2001 2013 1998 2000 2001 2001 1989 1000 2.0k 3.0k 4.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
    1998 4.0k citations Tohru Kitada, Shuichi Asakawa et al. profile →
  2. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
    2000 1.6k citations Hideki Shimura, Nobutaka Hattori et al. profile →
  3. An Unfolded Putative Transmembrane Polypeptide, which Can Lead to Endoplasmic Reticulum Stress, Is a Substrate of Parkin
    2001 882 citations Nobutaka Hattori, Yoshikuni Mizuno et al. profile →
  4. Ubiquitination of a New Form of α-Synuclein by Parkin from Human Brain: Implications for Parkinson's Disease
    2001 842 citations Hideki Shimura, Michael G. Schlossmacher et al. profile →
  5. Deficiencies in Complex I subunits of the respiratory chain in Parkinson's disease
    1989 589 citations Yoshikuni Mizuno, Keiji Suzuki et al. profile →
  6. Protein-bound acrolein: Potential markers for oxidative stress
    1998 561 citations Nobutaka Hattori, Yoshikuni Mizuno et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshikuni Mizuno Japan 78 14.8k 10.1k 9.7k 4.8k 4.5k 403 26.7k
Mark Cookson United States 81 13.5k 0.9× 11.6k 1.2× 6.4k 0.7× 4.0k 0.8× 6.2k 1.4× 258 24.9k
Serge Przedborski United States 110 21.8k 1.5× 14.3k 1.4× 15.3k 1.6× 8.4k 1.7× 7.8k 1.7× 261 41.6k
M. Flint Beal United States 105 11.7k 0.8× 19.9k 2.0× 15.1k 1.5× 4.2k 0.9× 7.8k 1.7× 273 36.4k
J. Timothy Greenamyre United States 83 11.2k 0.8× 11.4k 1.1× 13.2k 1.4× 3.4k 0.7× 4.1k 0.9× 208 25.6k
Alexis Brice France 88 16.2k 1.1× 16.9k 1.7× 18.9k 1.9× 6.7k 1.4× 6.1k 1.4× 548 35.8k
M. Flint Beal United States 98 9.5k 0.6× 19.5k 1.9× 9.0k 0.9× 4.2k 0.9× 10.2k 2.3× 221 36.5k
Étienne C. Hirsch France 89 16.2k 1.1× 9.2k 0.9× 15.1k 1.5× 7.2k 1.5× 4.6k 1.0× 311 31.8k
Edward Rockenstein United States 76 9.7k 0.7× 7.9k 0.8× 8.6k 0.9× 5.2k 1.1× 10.3k 2.3× 195 24.4k
Robert J. Ferrante United States 85 9.8k 0.7× 14.3k 1.4× 13.0k 1.3× 3.1k 0.6× 3.8k 0.8× 160 26.2k
Henry Houlden United Kingdom 70 7.0k 0.5× 8.9k 0.9× 7.0k 0.7× 5.1k 1.1× 6.7k 1.5× 512 20.7k

Countries citing papers authored by Yoshikuni Mizuno

Since Specialization
Citations

This map shows the geographic impact of Yoshikuni Mizuno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshikuni Mizuno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshikuni Mizuno more than expected).

Fields of papers citing papers by Yoshikuni Mizuno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshikuni Mizuno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshikuni Mizuno. The network helps show where Yoshikuni Mizuno may publish in the future.

Co-authorship network of co-authors of Yoshikuni Mizuno

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshikuni Mizuno. A scholar is included among the top collaborators of Yoshikuni Mizuno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshikuni Mizuno. Yoshikuni Mizuno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Li‐hao, et al.. (2024). Adult neurogenesis in the ventral hippocampus decreased among animal models of neurodevelopmental disorders. Frontiers in Neural Circuits. 18. 1504191–1504191. 1 indexed citations
2.
Nomoto, Masahiro, Yoshikuni Mizuno, Tomoyoshi Kondo, et al.. (2014). Transdermal rotigotine in advanced Parkinson’s disease: a randomized, double-blind, placebo-controlled trial. Journal of Neurology. 261(10). 1887–1893. 34 indexed citations
3.
Nishioka, Kenya, Manabu Funayama, Carles Vilariño‐Güell, et al.. (2014). EIF4G1 gene mutations are not a common cause of Parkinson's disease in the Japanese population. Parkinsonism & Related Disorders. 20(6). 659–661. 13 indexed citations
4.
Hayakawa, Hideki, Toru Yasuda, Tomoko Nihira, et al.. (2010). Ectopic expression of α‐synuclein affects the migration of neural stem cells in mouse subventricular zone. Journal of Neurochemistry. 115(4). 854–863. 13 indexed citations
5.
Apaydın, Hülya, Sibel Özekmekçi, Derya Uludüz, et al.. (2008). Homozygous PARK7 Mutation in Parkinson’s Disease: Case Report of Two Brothers. SHILAP Revista de lepidopterología. 2 indexed citations
6.
Watanabe, Masao, et al.. (2006). Clinical manifestations and etiology in stroke patients with cancer: usefulness of coagulation and fibrinolytic markers. Nosotchu. 28(3). 351–359. 6 indexed citations
7.
Oyama, Genko, Nana Izawa, Kenji Fujishima, et al.. (2005). Fusió d’imatges de satèl·lit. Implementació en OpenEV. PubMed. 57(11). 1003–6. 2 indexed citations
8.
Ide, Masayuki, Kazuo Yamada, Tomoko Toyota, et al.. (2005). Genetic association analyses of PHOX2B and ASCL1 in neuropsychiatric disorders: evidence for association of ASCL1 with Parkinson’s disease. Human Genetics. 117(6). 520–527. 23 indexed citations
9.
Motoi, Yumiko, Hideo Mori, Yoshikuni Mizuno, et al.. (2004). Apolipoprotein E receptor 2 is involved in neuritic plaque formation in APP sw mice. Neuroscience Letters. 368(2). 144–147. 16 indexed citations
10.
Okuma, Yasuyuki, et al.. (2002). Head tremor in dentatorubral-pallidoluysian atrophy. Acta Neurologica Scandinavica. 106(5). 319–321. 1 indexed citations
11.
Schlossmacher, Michael G., Matthew P. Frosch, Wei Gai, et al.. (2002). Parkin Localizes to the Lewy Bodies of Parkinson Disease and Dementia with Lewy Bodies. American Journal Of Pathology. 160(5). 1655–1667. 255 indexed citations
12.
Urabe, Takao, Ryota Tanaka, Kazuyuki Noda, & Yoshikuni Mizuno. (2002). Anticoagulant Therapy with a Selective Thrombin Inhibitor for Acute Cerebral Infarction: Usefulness of Coagulation Markers for Evaluation of Efficacy. Journal of Thrombosis and Thrombolysis. 13(3). 155–160. 8 indexed citations
13.
Yamamoto, Takeshi, et al.. (2000). Long‐Term Improvement of Idiopathic Hypertrophic Cranial Pachymeningitis by Lymphocytapheresis. Therapeutic Apheresis. 4(4). 313–316. 13 indexed citations
14.
Hattori, Nobutaka, Hideki Shimura, Shinichiro Kubo, et al.. (2000). Autosomal recessive juvenile parkinsonism: A key to understanding nigral degeneration in sporadic Parkinson's disease. Neuropathology. 20(s1). 85–90. 21 indexed citations
15.
Kobayashi, Tomonori, et al.. (2000). Exonic deletion mutations of the Parkin gene among sporadic patients with Parkinson's disease. Parkinsonism & Related Disorders. 6(3). 129–131. 16 indexed citations
16.
Mogi, Makio, Minoru Harada, Tomoyoshi Kondo, et al.. (1996). The soluble form of Fas molecule is elevated in parkinsonian brain tissues. Neuroscience Letters. 220(3). 195–198. 70 indexed citations
17.
Furukawa, Yoshiaki, Katsunori Nishi, Tomoyoshi Kondo, Yoshikuni Mizuno, & Hirotaro Narabayashi. (1992). Juvenile parkinsonism: ventricular CSF biopterin levels and clinical features. Journal of the Neurological Sciences. 108(2). 207–213. 8 indexed citations
18.
Urabe, Takao, et al.. (1992). Evaluation of cerebral infarction using B-mode ultrasonic and doppler flowmeter.. Nosotchu. 14(3). 241–251. 1 indexed citations
19.
Suzuki, Keiji, et al.. (1989). Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes with special reference to the mechanism of cerebral manifestations. Acta Neurologica Scandinavica. 80(6). 561–568. 17 indexed citations
20.
Mizuno, Yoshikuni, et al.. (1988). Effects of Indeloxazine, (+)-2-[Inden-7-yloxy)methyl]morpholine Hydrochloride on Cerebrospinal Fluid Monoamine Metabolites. European Neurology. 28(2). 84–86. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark Cookson Breakdown of academic impact, for papers by Serge Przedborski Breakdown of academic impact, for papers by M. Flint Beal Breakdown of academic impact, for papers by J. Timothy Greenamyre Breakdown of academic impact, for papers by Alexis Brice Breakdown of academic impact, for papers by M. Flint Beal Breakdown of academic impact, for papers by Étienne C. Hirsch Breakdown of academic impact, for papers by Edward Rockenstein Breakdown of academic impact, for papers by Robert J. Ferrante Breakdown of academic impact, for papers by Henry Houlden
Rankless by CCL
2026